News & Perspective

Jun 16, 2014

Jun 16, 2014
Novartis Holly Springs

FDA OKs Novartis's US cell-based flu vaccine facility

The agency has approved a plant in Holly Springs, N.C.

Feb 21, 2013

Feb 21, 2013

CDC midseason check finds scant flu vaccine effect for seniors

(CIDRAP News) – Influenza vaccine over the past few months has provided moderate protection overall but didn't have a significant impact on protecting seniors, a study from the US Centers for Disease Control and Prevention (CDC) revealed today.

Jan 11, 2013

Jan 11, 2013

CDC's early-season look finds flu vaccine 62% effective

(CIDRAP News) – An early assessment of this year's influenza vaccine shows it has provided a "moderate" level of protection at 62% so far this season, the Centers for Disease Control and Prevention (CDC) said today. That vaccine effectiveness (VE) level is about the same as in recent seasons and as found in a recent careful meta-analysis of randomized controlled trials.

Oct 15, 2012

Oct 15, 2012

A game-changing approach to investigating flu vaccines

Editor’s Note: This article covers research conducted by CIDRAP scientists. Please note that CIDRAP News operates independently in relation to CIDRAP's research and policy programs.

Mar 11, 2011

Mar 11, 2011

Study: Some trials overestimated flu vaccine efficacy

(CIDRAP News) – Researchers from the University of Michigan say one measure of flu vaccine efficacy that has been used in a number of past controlled trials is not very accurate, and that this may have led to a degree of overselling of the protection the vaccines provide.

Feb 11, 2011

Feb 11, 2011

Study showing high effectiveness for H1N1 vaccine stirs debate

(CIDRAP News) – A recent case-control study estimates that the adjuvanted pandemic H1N1 influenza vaccine used in Canada was effective 93% of the time, a substantially higher figure than seen in several other studies and one that has raised some eyebrows among other flu vaccine researchers.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»